Interestingly, the disease recurrences that developed in the four women with triple-negative tumours and in the one woman with a HER2-positive tumour were all limited to locoregional sites, with no systemic diseases detected either concurrently or at a later time. The gene discussed is ERBB2; the disease is neoplasm.